LONIKOS

LONIKOS

SKU: eb7c6a1295d3 Category: INJECTION

L-Orinithine L-Asparate

1 in stock


L-Ornithine and L-Aspartate Injection | Lonikos

Lonikos Injection is a medication that combines two amino acids, L-ornithine and L-aspartate. It is used for the treatment of certain liver conditions, such as hepatic encephalopathy, which is a brain disorder that occurs due to liver dysfunction. L-ornithine and L-aspartate injection works by protecting the liver from harmful substances and preventing liver damage.

Uses of L-Ornithine and L-Aspartate Injection

L-Ornithine and L-aspartate Injection is primarily used for the treatment of hepatic encephalopathy, a condition characterized by impaired brain function due to liver disease. It helps reduce the symptoms associated with hepatic encephalopathy, such as confusion, disorientation, and changes in behaviour. L-Ornithine and L-aspartate Injection may also be used in the management of other liver conditions, but its primary use is for hepatic encephalopathy.

Benefits of using L-ornithine and L-aspartate injection

  1. Lowers blood ammonia levels: It helps to reduce the amount of ammonia present in the blood.
  2. Increases amino acids: It helps to boost the number of amino acids, including arginine, in the body.
  3. Reduces ammonia levels: It helps to decrease the levels of ammonia in the body.
  4. Minimizes health risks: By avoiding elevated ammonia levels in the body, it helps to prevent associated health risks.
  5. Protects the liver: It has liver-protecting properties, particularly for patients with fatty liver.

Side effects of using L-ornithine and L-aspartate injection

  • Headache
  • Fatigue
  • Nausea
  • Diarrhoea
  • Abdominal pain

Precautions of L-ornithine and L-aspartate injection

Some individuals may be allergic to L-ornithine and L-aspartate injections. It is important to inform your healthcare provider if you have a known allergy to any of the ingredients in the injection.

  • L-ornithine and L-aspartate injection is primarily used in the management of hepatic encephalopathy, a condition that occurs in people with liver disease. However, the safety and efficacy of L-ornithine and L-aspartate injection in individuals with severe liver disease or other liver conditions have not been well-established. It is important to consult with a healthcare professional before using this injection if you have liver disease.
  • L-ornithine and L-aspartate injections may interact with certain medications. It is important to inform your healthcare provider about all the medications, supplements, and herbal products you are taking before starting L-ornithine and L-aspartate injections. This will help ensure that there are no potential drug interactions.
  • The safety of L-ornithine and L-aspartate injection during pregnancy and breastfeeding has not been well-studied. It is important to consult with a healthcare professional before using this injection if you are pregnant or breastfeeding.

Additional information

Pack Size